Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / NBIX - Neurocrine Biosciences picks former Eli Lilly executive as chief scientific officer

NBIX - Neurocrine Biosciences picks former Eli Lilly executive as chief scientific officer

Neurocrine Biosciences Inc.
Neurocrine Biosciences (NBIX -1.8%) announced the appointment of Jude Onyia as the company’s Chief Scientific Officer. A 25-year veteran in the pharmaceutical industry, Dr. Onyia last served as Chief Scientific Officer at Capsida Biotherapeutics. Before that, he worked at Eli Lilly (NYSE:LLY) as Vice President of Biotechnology Discovery Research after starting his 25-year career there as a post-doctoral research fellow. "Jude is an industry leader with a proven track record and a deep passion for drug discovery," CEO of Neurocrine (NASDAQ:NBIX), Kevin Gorman, noted.

For further details see:

Neurocrine Biosciences picks former Eli Lilly executive as chief scientific officer
Stock Information
Company Name: Neurocrine Biosciences Inc.
Stock Symbol: NBIX
Market: NASDAQ
Website: neurocrine.com
Menu
NBIX NBIX Quote NBIX Short NBIX News NBIX Articles NBIX Message Board
Get NBIX Alerts

News, Short Squeeze, Breakout and More Instantly...